Mathematical analysis of a two-strain tuberculosis model in Bangladesh

Sci Rep. 2022 Mar 7;12(1):3634. doi: 10.1038/s41598-022-07536-2.

Abstract

Tuberculosis (TB) is an airborne infectious disease that causes millions of deaths worldwide each year (1.2 million people died in 2019). Alarmingly, several strains of the causative agent, Mycobacterium tuberculosis (MTB)-including drug-susceptible (DS) and drug-resistant (DR) variants-already circulate throughout most developing and developed countries, particularly in Bangladesh, with totally drug-resistant strains starting to emerge. In this study we develop a two-strain DS and DR TB transmission model and perform an analysis of the system properties and solutions. Both analytical and numerical results show that the prevalence of drug-resistant infection increases with an increasing drug use through amplification. Both analytic results and numerical simulations suggest that if the basic reproduction numbers of both DS ([Formula: see text]) and DR ([Formula: see text]) TB are less than one, i.e. [Formula: see text] the disease-free equilibrium is asymptotically stable, meaning that the disease naturally dies out. Furthermore, if [Formula: see text], then DS TB dies out but DR TB persists in the population, and if [Formula: see text] both DS TB and DR TB persist in the population. Further, sensitivity analysis of the model parameters found that the transmission rate of both strains had the greatest influence on DS and DR TB prevalence. We also investigated the effect of treatment rates and amplification on both DS and DR TB prevalence; results indicate that inadequate or inappropriate treatment makes co-existence more likely and increases the relative abundance of DR TB infections.

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Bangladesh / epidemiology
  • Basic Reproduction Number
  • Humans
  • Mycobacterium tuberculosis*
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents